THE ROLE OF METHOTREXATE IN OSTEO-SARCOMA

[1] TRANSIENT CEREBRAL-DYSFUNCTION FOLLOWING CHEMOTHERAPY FOR OSTEOGENIC-SARCOMA [J]. ANNALS OF NEUROLOGY, 1978, 3 (05) : 441 - 444

[2] ALLEN JC, 1980, CANCER TREAT REP, V64, P1261

[3] AMBINDER EP, 1979, CANCER-AM CANCER SOC, V43, P1177, DOI 10.1002/1097-0142(197904)43:4<1177::AID-CNCR2820430403>3.0.CO

[4] 2-R

[5] [Anonymous], 1978, Recent Results Cancer Res, V68, P28

[6] ANZAI T, 1986, METHOTREXATE CANCER, P55

[7] BACCI G, 1979, TUMORI J, V65, P587

[8] ADRIAMYCIN METHOTREXATE HIGH-DOSE VERSUS ADRIAMYCIN METHOTREXATE MODERATE DOSE AS ADJUVANT CHEMOTHERAPY FOR OSTEOSARCOMA OF THE EXTREMITIES - A RANDOMIZED STUDY [J]. EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1986, 22 (11): : 1337 - 1345

[9] BARNES R, 1986, British Journal of Cancer, V53, P513

[10] BAUM ES, 1981, CANCER TREAT REP, V65, P815

[1] TRANSIENT CEREBRAL-DYSFUNCTION FOLLOWING CHEMOTHERAPY FOR OSTEOGENIC-SARCOMA [J]. ANNALS OF NEUROLOGY, 1978, 3 (05) : 441 - 444

[2] ALLEN JC, 1980, CANCER TREAT REP, V64, P1261

[3] AMBINDER EP, 1979, CANCER-AM CANCER SOC, V43, P1177, DOI 10.1002/1097-0142(197904)43:4<1177::AID-CNCR2820430403>3.0.CO

[4] 2-R

[5] [Anonymous], 1978, Recent Results Cancer Res, V68, P28

[6] ANZAI T, 1986, METHOTREXATE CANCER, P55

[7] BACCI G, 1979, TUMORI J, V65, P587

[8] ADRIAMYCIN METHOTREXATE HIGH-DOSE VERSUS ADRIAMYCIN METHOTREXATE MODERATE DOSE AS ADJUVANT CHEMOTHERAPY FOR OSTEOSARCOMA OF THE EXTREMITIES - A RANDOMIZED STUDY [J]. EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1986, 22 (11): : 1337 - 1345

[9] BARNES R, 1986, British Journal of Cancer, V53, P513

[10] BAUM ES, 1981, CANCER TREAT REP, V65, P815